The DOI matches its Crossref record; 163 of the 166 references it cites were found in a registry or an index.
A decade of exploring the cancer epigenome—biological and translational implications
Open accessAbstract
The past decade has highlighted the central role of epigenetic processes in cancer causation, progression and treatment. Next-generation sequencing is providing a window for visualizing the human epigenome and how it is altered in cancer. This view provides many surprises, including linking epigenetic abnormalities to mutations in genes that control DNA methylation, the packaging and the function of DNA in chromatin, and metabolism. Epigenetic alterations are leading candidates for the development of specific markers for cancer detection, diagnosis and prognosis. The enzymatic processes that control the epigenome present new opportunities for deriving therapeutic strategies designed to reverse transcriptional abnormalities that are inherent to the cancer epigenome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conversely, disruption of chromosomal topology and oncogene insulation may be more generally relevant to methylator phenotypes observed in colorectal and renal cell carcinomas, leukemia and other malignancies28.”
From Insulator dysfunction and oncogene activation in IDH mutant gliomas (2016) · cites this paper as [28]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies showed that enhanced histone acetylation induced by HDACi allowed the overexpression of genes involved in cell cycle arrest such as cyclin-dependent kinase inhibitors or the growth arrest and DNA damage-inducible protein GADD45 gene family (11, 28, 40, 45-49).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Insulator dysfunction may also be accompanied by promoter silencing events28,29, and by alterations to other pathways affected by 2-HG7,30.”
From Insulator dysfunction and oncogene activation in IDH mutant gliomas (2016) · cites this paper as [28]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Among them, novel selective benzamide-based HDAC1/2 inhibitors have been described that exhibit greater than 100-fold selectivity relative to other HDACs (11, 28).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“It has previously been shown that HDAC inhibitors such as SAHA and MS-275 promote cell cycle arrest and apoptosis”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measured
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Among activated genes that subside with pulsed HDACi administration are genes known to be powerful effectors of cell cycle arrest in multiple cell types and may promote apoptosis (11, 50).”
From Histone Deacetylase (HDAC) Inhibitor Kinetic Rate Constants Correlate with Cellular Histone Acetylation but Not Transcription and Cell Viability (2013) · cites this paper as [11]
Experimental — accuracy not yet measuredIn the citing paper
“Three general processes have major effects on cancer initiation and progression. First, discrete somatic mutations lead to tumor suppressor loss-of-function and oncoprotein gain-of-function [1]; second, epigenetic alterations change patterns of gene expression [2]; and third, alterations in the tumor microenvironment also lead to broad changes in gene expression [3].”
From The hypoxic tumor microenvironment: A driving force for breast cancer progression (2016) · cites this paper as [2]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
DNA methylation patterns and epigenetic memory
Bird, A. (2002) · Genes & Development · doi:10.1101/gad.947102 · Cited by 7,124
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1
Tahiliani, M., Koh, K. P., Shen, Y., Pastor, W. A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L. M., Liu, D. R., Aravind, L., et al. (2009) · Science · doi:10.1126/science.1170116 · Cited by 5,836
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Self-citationA bivalent chromatin structure marks key developmental genes in embryonic stem cells
Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.041 · Cited by 5,361
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,205
Flagged first, then by citations
3 of the 166 references couldn’t be matched to a known paper.
Research works printed but not linked: 3
- Allis, C., Jenuwein, T. & Reinberg, D. Epigenetics (ed. Caparros, M.) (Cold Spring Harbor Laboratory Press, 2007).
- Allis, C. D., Jenuwein, T, Reinberg, D. Overview and concepts (Cold Spring Harbor Laboratory Press, New York, 2007).
- Gilbert, M. R. et al. in ASCO Annual Meeting 2011 Abstr. 2006. (University of Texas M. D. Anderson Cancer Center, Chicago, 2011).
Cited by
Sorted by citations
Items 301–400 of 1,001
Complexity of cancer stem cells
Sugihara, E., & Saya, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.27961 · Cited by 132
Lechner, M., Fenton, T. R., West, J., Wilson, G. A., Feber, A., Henderson, S. R., Thirlwell, C., Dibra, H. K., Jay, A., Butcher, L. M., et al. (2013) · Genome Medicine · doi:10.1186/gm419 · Cited by 128
The epigenetic landscape of renal cancer
Morris, M. R., & Latif, F. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.168 · Cited by 129
Cancer stem cell: Fundamental experimental pathological concepts and updates
Islam, F., Qiao, B., Smith, R. A., Gopalan, V., & Lam, A. K.-Y. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.02.002 · Cited by 131
DNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Xie, W., Kagiampakis, I., Pan, L., Zhang, Y. W., Murphy, L., Tao, Y., Kong, X., Kang, B., Xia, L., Carvalho, F. L. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.008 · Cited by 122
Self-citationDecoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
Queirós, A. C., Beekman, R., Vilarrasa‐Blasi, R., Duran‐Ferrer, M., Clot, G., Merkel, A., Raineri, E., Russiñol, N., Castellano, G., Beà, S., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.014 · Cited by 122
The mutational landscape of chromatin regulatory factors across 4,623 tumor samples
González-Pérez, A., Jené-Sanz, A., & López-Bigas, N. (2013) · Genome biology · doi:10.1186/gb-2013-14-9-r106 · Cited by 131
Wong, C. P., Hsu, A., Buchanan, A., Palomera‐Sánchez, Z., Beaver, L. M., Houseman, E. A., Williams, D. E., Dashwood, R. H., & Ho, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086787 · Cited by 125
Regulation of deoxynucleotide metabolism in cancer: novel mechanisms and therapeutic implications
Kohnken, R. A., Kodigepalli, K. M., & Wu, L. J. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0446-6 · Cited by 128
Epigenetics in Breast and Prostate Cancer
Wu, Y., Sarkissyan, M., & Vadgama, J. V. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-1804-1_23 · Cited by 128
Evolving insights on how cytosine methylation affects protein-DNA binding
Dantas Machado, A. C., Zhou, T., Rao, S., Goel, P., Rastogi, C., Lazarovici, A., Bussemaker, H. J., & Rohs, R. (2015) · Briefings in Functional Genomics · doi:10.1093/bfgp/elu040 · Cited by 124
Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway
Goeppert, B. F., Konermann, C., Schmidt, C. R., Bogatyrova, O., Geiselhart, L., Ernst, C., Gu, L., Becker, N., Zucknick, M., Mehrabi, A., et al. (2013) · Hepatology · doi:10.1002/hep.26721 · Cited by 123
Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
Lee, J. Y., Friso, S., & Choi, S. (2014) · Nutrients · doi:10.3390/nu6083303 · Cited by 125
Robles, A. I., Arai, E., Mathé, E. A., Okayama, H., Schetter, A. J., Brown, D. W., Petersen, D. W., Bowman, E. D., Noro, R., Welsh, J. A., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000560 · Cited by 123
Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers
Cha, S.-R., Jang, J., Park, S., Ryu, S. M., Cho, S.-J., & Yang, S. (2023) · Antioxidants · doi:10.3390/antiox12061210 · Cited by 143
miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
Amodio, N., Rossi, M., Raimondi, L., Pitari, M. R., Botta, C., Tagliaferri, P., & Tassone, P. (2015) · Oncotarget · doi:10.18632/oncotarget.3805 · Cited by 123
Association between DNA Methylation in Whole Blood and Measures of Glucose Metabolism: KORA F4 Study
Kriebel, J., Herder, C., Rathmann, W., Wahl, S., Kunze, S., Molnos, S., Volkova, N. V., Schramm, K., Carstensen‐Kirberg, M., Waldenberger, M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0152314 · Cited by 118
Leichter, A. L., Sullivan, M. J., Eccles, M. R., & Chatterjee, A. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0584-0 · Cited by 120
AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis
Li, N., Xue, W., Yuan, H., Dong, B., Ding, Y., Liu, Y., Jiang, M., Kan, S., Sun, T., Ren, J., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci91144 · Cited by 119
Blagitko‐Dorfs, N., Schlosser, P., Greve, G., Pfeifer, D., Meier, R., Baude, A., Brocks, D., Plass, C., & Lübbert, M. (2018) · Leukemia · doi:10.1038/s41375-018-0293-8 · Cited by 120
Emerging Understanding of Multiscale Tumor Heterogeneity
Gerdes, M. J., Sood, A., Sevinsky, C. J., Pris, A. D., Zavodszky, M. I., & Ginty, F. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00366 · Cited by 125
Genomic Medicine Frontier in Human Solid Tumors: Prospects and Challenges
Dienstmann, R., Rodon, J. A., Barretina, J., & Tabernero, J. M. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.45.2268 · Cited by 120
Epigenetic supersimilarity of monozygotic twin pairs
Baak, T. E. V., Coarfa, C., Dugué, P., Fiorito, G., Laritsky, E., Baker, M. S., Kessler, N. J., Dong, J., Duryea, J., Silver, M. J., et al. (2018) · Genome biology · doi:10.1186/s13059-017-1374-0 · Cited by 114
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
López-Serra, P., Marcilla, M., Villanueva, A., Ramos-Fernández, A., Palau, A., Leal, L., Wahi, J. E., Setien-Baranda, F., Szczęsna, K., Moutinho, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4608 · Cited by 118
Ma, F., Lei, Y., Ding, M.-G., Luo, L., Xie, Y., & Liu, X. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00250 · Cited by 117
The role of 5-hydroxymethylcytosine in human cancer
Pfeifer, G. P., Xiong, W., Hahn, M. A., & Jin, S. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1896-7 · Cited by 118
Zhuang, J. J., Jones, A., Lee, S., Ng, E., Fiegl, H., Zikán, M., Cibula, D., Sargent, A., Salvesen, H. B., Jacobs, I. J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002517 · Cited by 117
Role of Base Excision “Repair” Enzymes in Erasing Epigenetic Marks from DNA
Drohat, A. C., & Coey, C. T. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00191 · Cited by 118
Zebrafish as a model to study the role of DNA methylation in environmental toxicology
Kamstra, J. H., Aleström, P., Kooter, J. M., & Legler, J. (2014) · Environmental Science and Pollution Research · doi:10.1007/s11356-014-3466-7 · Cited by 118
TET2 as an epigenetic master regulator for normal and malignant hematopoiesis
Nakajima, H., & Kunimoto, H. (2014) · Cancer Science · doi:10.1111/cas.12484 · Cited by 117
Hilakivi-Clarke, L. A. (2014) · Breast Cancer Research · doi:10.1186/bcr3649 · Cited by 112
Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms
Lewis, K. A., & Tollefsbol, T. O. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00083 · Cited by 112
Epigenetic Alterations in Human Papillomavirus-Associated Cancers
Soto, D. R., Song, C., & McLaughlin-Drubin, M. E. (2017) · Viruses · doi:10.3390/v9090248 · Cited by 116
Role of base excision repair in maintaining the genetic and epigenetic integrity of CpG sites
Bellacosa, A., & Drohat, A. C. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.04.011 · Cited by 112
Neuroblastoma and the epigenome
Fetahu, I. S., & Taschner‐Mandl, S. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09946-y · Cited by 114
Kim, Y., Yoon, H. Y., Kim, J. S., Kang, H. W., Min, B.-D., Kim, S., Ha, Y., Kim, I. Y., Ryu, K. H., Lee, S., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28121 · Cited by 110
Epigenetic therapy in gastrointestinal cancer: the right combination
Abdelfatah, E., Kerner, Z. J., Nanda, N., & Ahuja, N. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16644247 · Cited by 115
Stueve, T. R., Li, W., Shi, J., Marconett, C. N., Zhang, T., Yang, C., Mullen, D. J., Yan, C., Wheeler, W., Hua, X., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx188 · Cited by 110
The role of DNA methylation in directing the functional organization of the cancer epigenomePreprint
Lay, F. D., Liu, Y., Kelly, T. K., Witt, H. N., Farnham, P., Jones, P. A., & Berman, B. P. (2015) · Genome Research · doi:10.1101/gr.183368.114 · Cited by 111
Self-citationAttig, J., Young, G. R., Hosie, L., Perkins, D., Encheva-Yokoya, V., Stoye, J. P., Snijders, A. P., Ternette, N., & Kassiotis, G. (2019) · Genome Research · doi:10.1101/gr.248922.119 · Cited by 113
Targeting the histone orthography of cancer: drugs for writers, erasers and readers
Simó‐Riudalbas, L., & Esteller, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12844 · Cited by 111
Epigenetic Mechanisms in Gastric Cancer
Gigek, C. O., Chen, E., Calcagno, D. Q., Wisnieski, F., Burbano, R. M. R., & Smith, M. D. A. C. (2012) · Epigenomics · doi:10.2217/epi.12.22 · Cited by 109
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer
Raynal, N. J. ‐., Lee, J. T., Wang, Y., Beaudry, A., Madireddi, P., Garriga, J., Malouf, G. G., Dumont, S., Dettman, E. J., Gharibyan, V., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-14-2391 · Cited by 106
Self-citationSOX9: An emerging driving factor from cancer progression to drug resistance
Panda, M., Tripathi, S. K., & Biswal, B. K. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188517 · Cited by 109
Calling differentially methylated regions from whole genome bisulphite sequencing with DMRcate
Peters, T. J., Buckley, M. J., Chen, Y., Smyth, G. K., Goodnow, C. C., & Clark, S. J. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab637 · Cited by 113
Sakamoto, A., Hino, S., Nagaoka, K., Anan, K., Takase, R., Matsumori, H., Ojima, H., Kanai, Y., Arita, K., & Nakao, M. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1560 · Cited by 113
Epigenetic regulation of hepatocellular carcinoma in non-alcoholic fatty liver disease
Tian, Y., Wong, V. W., Chan, H. L., & Cheng, A. S. L. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.08.010 · Cited by 108
Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.
Darwiche, N. (2020) · PubMed Central · Cited by 105
Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma
Kresse, S. H., Rydbeck, H., Skårn, M., Namløs, H. M., Barragan-Polania, A. H., Cleton-Jansen, A., Serra, M., Liestøl, K., Hogendoorn, P. C. W., Hovig, E. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048262 · Cited by 106
Ouyang, L., Hu, Y., Zhu, L., Cheng, G. J., & Irudayaraj, J. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.09.072 · Cited by 107
dCas9: A Versatile Tool for Epigenome Editing
Brocken, D. J. W., Tark‐Dame, M., & Dame, R. T. (2017) · Current Issues in Molecular Biology · doi:10.21775/cimb.026.015 · Cited by 113
Metabolic recoding of epigenetics in cancer
Wang, Y., & Lei, Q. (2018) · 癌症：英文版 · doi:10.1186/s40880-018-0302-3 · Cited by 109
Begley, T. J., & Dedon, P. C. (2014) · PubMed Central · doi:10.1021/tx400438d · Cited by 106
Epigenetic Modifications in Breast Cancer and Their Role in Personalized Medicine
Stefánsson, Ó. A., & Esteller, M. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.033 · Cited by 111
Chatterjee, R., & Vinson, C. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2012.02.014 · Cited by 109
Epigenetic Effects of Green Tea Polyphenols in Cancer
Henning, S. M., Wang, P., Carpenter, C. L., & Heber, D. (2013) · Epigenomics · doi:10.2217/epi.13.57 · Cited by 106
Ando, M., Saito, Y., Xu, G., Bui, N. Q., Medetgul-Ernar, K., Pu, M., Fisch, K. M., Ren, S., Sakai, A., Fukusumi, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09937-w · Cited by 108
Single-molecule footprinting identifies context-dependent regulation of enhancers by DNA methylation
Kreibich, E., Kleinendorst, R., Barzaghi, G., Kaspar, S., & Krebs, A. R. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.01.017 · Cited by 106
Liang, W.-W., Lu, R. J.-H., Jayasinghe, R. G., Foltz, S. M., Porta-Pardo, E., Geffen, Y., Wendl, M. C., Lazcano, R., Kolodziejczak, I., Song, Y., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.013 · Cited by 105
Endoplasmic Reticulum Stress, Genome Damage, and Cancer
Dicks, N., Gutierrez, K., Michalak, M., Bordignon, V., & Agellon, L. B. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00011 · Cited by 106
Epigenetic modifiers as new immunomodulatory therapies in solid tumours
Aspeslagh, S., Morel, D., Soria, J., & Postel-Vinay, S. C. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy050 · Cited by 105
H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers
Dong, F., Gan, H., Cheng, L., Lee, J., Zhou, H., Sarkaria, J. N., Daniels, D. J., & Zhang, Z. (2018) · eLife · doi:10.7554/elife.36696 · Cited by 106
Targeted Therapies and Biomarkers in Small Cell Lung Cancer
Taniguchi, H., Sen, T., & Rudin, C. M. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00741 · Cited by 105
O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer
Parker, M. P., Peterson, K. R., & Slawson, C. M. (2021) · Cancers · doi:10.3390/cancers13071666 · Cited by 108
Epigenetic Changes in Pediatric Solid Tumors: Promising New Targets
Lawlor, E. R., & Thiele, C. J. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1921 · Cited by 104
A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells
Barciszewska, A., Gurda, D., Głodowicz, P., Nowak, S., & Naskręt-Barciszewska, M. Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136669 · Cited by 101
Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
Camuzi, D., de Amorim, Í. S. S., Pinto, L. F. R., Trivilin, L. O., Mencalha, A. L., & Soares‐Lima, S. C. (2019) · Cells · doi:10.3390/cells8040300 · Cited by 109
Abu-Remaileh, M., Bender, S., Raddatz, G., Ansari, I., Cohen, D., Gutekunst, J., Musch, T., Linhart, H., Breiling, A., Pikarsky, E., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3295 · Cited by 102
Gene promoter methylation and cancer: An umbrella review
Bouras, E., Karakioulaki, M., Bougioukas, K. I., Aivaliotis, M., Tzimagiorgis, G., & Chourdakis, M. (2019) · Gene · doi:10.1016/j.gene.2019.06.023 · Cited by 99
Epigenetic Modifications in the Pathogenesis of Diabetic Nephropathy
Reddy, M. A., Park, J. T., & Natarajan, R. D. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.05.006 · Cited by 100
Prognostic DNA Methylation Markers for Prostate Cancer
Strand, S. H., Orntoft, T. F., & Sørensen, K. D. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150916544 · Cited by 106
1p36 Tumor Suppression—A Matter of Dosage?
Henrich, K., Schwab, M., & Westermann, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2230 · Cited by 103
Gentile, T. L., Lü, C., Lodato, P. M., Tse, S., Olejniczak, S. H., Witze, E. S., Thompson, C. B., & Wellen, K. E. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01495-12 · Cited by 102
Menin Epigenetically Represses Hedgehog Signaling in MEN1 Tumor Syndrome
Gurung, B., Feng, Z., Iwamoto, D. V., Thiel, A. T., Jin, G., Fan, C.-M., Ng, J. M. Y., Curran, T., & Hua, X. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3158 · Cited by 101
Jin, B., Ernst, J., Tiedemann, R. L., Xu, H., Sureshchandra, S., Kellis, M., Dalton, S., Liu, C., Choi, J.-H., & Robertson, K. D. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.10.017 · Cited by 103
Siebenkäs, C., Chiappinelli, K. B., Guzzetta, A. A., Sharma, A. R., Jeschke, J., Vatapalli, R. J., Baylin, S. B., & Ahuja, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179501 · Cited by 100
Self-citationEmerging Roles for Long Non-Coding RNAs in Cancer and Neurological Disorders
Niland, C. N., Merry, C. R., & Khalil, A. M. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00025 · Cited by 103
Cheng, P. F., Shakhova, O., Widmer, D. S., Eichhoff, O. M., Zingg, D., Frommel, S. C., Belloni, B., Raaijmakers, M. I., Goldinger, S. M., Santoro, R., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0594-4 · Cited by 100
The promise and failures of epigenetic therapies for cancer treatment
Bojang, P., & Ramos, K. S. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.05.009 · Cited by 101
Cowley, A. W., Nadeau, J. H., Baccarelli, A., Berecek, K. H., Fornage, M., Gibbons, G. H., Harrison, D. G., Liang, M., Nathanielsz, P. W., O’Connor, D. T., et al. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.190116 · Cited by 100
Forootan, F. S., Forootan, S. S., Gou, X., Yang, J. K., Liu, B., Chen, D., Fayi, M. S. A., Al-Jameel, W. H., Rudland, P. S., Hussain, S. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6975 · Cited by 98
Emerging Molecular and Biological Functions of MBD2, a Reader of DNA Methylation
Wood, K. H., & Zhou, Z. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00093 · Cited by 104
Dietary antioxidants remodel DNA methylation patterns in chronic disease
Beetch, M., Harandi‐Zadeh, S., Shen, K., Lubecka, K., Kitts, D. D., O’Hagan, H. M., & Stefañska, B. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14888 · Cited by 105
Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas
Hu, X., Estecio, M. R., Chen, R., Reuben, A., Wang, L., Fujimoto, J., Carrot‐Zhang, J., McGranahan, N., Ying, L., Fukuoka, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-20907-z · Cited by 100
HDAC inhibitors: A new promising drug class in anti-aging research
Pasyukova, E. G., & Vaiserman, A. M. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.008 · Cited by 99
Moutinho, C., Martínez‐Cardús, A., Santos, C., Navarro-Perez, V., Martinez‐Balibrea, E., Musulén, E., Carmona, F. J., Bianchi, A. S., Cassingena, A., Siena, S., et al. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt322 · Cited by 103
Martínez‐Fernández, L., Pepino, A. J., Segarra‐Martí, J., Jovaišaitė, J., Vayá, I., Nenov, A., Markovitsi, D., Gustavsson, T., Bányász, Á., Garavelli, M., et al. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b01145 · Cited by 98
DNA Methylation Regulates Alternative Polyadenylation via CTCF and the Cohesin Complex
Nanavaty, V., Abrash, E. W., Hong, C., Park, S., Fink, E. E., Li, Z., Sweet, T. J., Bhasin, J., Singuri, S., Lee, B., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.024 · Cited by 101
Liu, Y., Wang, J., Li, L., Qin, H., Wei, Y., Zhang, X., Ren, X., Ding, W., Shen, X., Li, G., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07070-1 · Cited by 99
Byun, J. S., & Gardner, K. L. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.01.009 · Cited by 104
Vitamin C – A new player in regulation of the cancer epigenome
Gillberg, L., Ørskov, A. D., Liu, M., Harsløf, L. B. S., Jones, P. A., & Grønbæk, K. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.001 · Cited by 100
Self-citationThe Role of piRNA and its Potential Clinical Implications in Cancer
Assumpção, C. B., Calcagno, D. Q., Araújo, T. M. T., dos Santos, S. E. B., dos Santos, Â. K. C. R., Riggins, G. J., Burbano, R. M. R., & de Assumpção, P. P. (2015) · Epigenomics · doi:10.2217/epi.15.37 · Cited by 99
Nikitakis, N. G., Pentenero, M., Georgaki, M., Poh, C. F.-Y., Peterson, D. E., Edwards, P. C., Lingen, M. W., & Sauk, J. J. (2018) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2018.03.012 · Cited by 98
The Cancer Epigenome: Exploiting Its Vulnerabilities for Immunotherapy
Yau, H. L., Ettayebi, I., & Carvalho, D. D. D. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.07.006 · Cited by 99
Schmitz, M., Eichelkraut, K., Schmidt, D., Zeiser, I., Hilal, Z., Tettenborn, Z., Hansel, A., & Ikenberg, H. (2018) · BMC Cancer · doi:10.1186/s12885-018-5125-8 · Cited by 101
Unravelling the genomic targets of small molecules using high-throughput sequencing
Rodriguez, R., & Miller, K. M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3796 · Cited by 100
The ketogenic diet for the treatment of malignant glioma
Woolf, E. C., & Scheck, A. C. (2014) · Journal of Lipid Research · doi:10.1194/jlr.r046797 · Cited by 96
Functional Genomic Studies: Insights into the Pathogenesis of Liver Cancer
Han, Z. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090711-163752 · Cited by 98
The mitochondrial side of epigenetics
Castegna, A., Iacobazzi, V., & Infantino, V. (2015) · Physiological Genomics · doi:10.1152/physiolgenomics.00096.2014 · Cited by 100
Current Insights into Oral Cancer Epigenetics
Irimie, A. I., Ciocan, C. A., Gulei, D., Mehterov, N. H., Atanasov, A. G., Dudea, D., & Berindan‐Neagoe, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030670 · Cited by 101
Metadata
- Authors
- Baylin, S. B., & Jones, P. A.
- Affiliations
- Johns Hopkins University (US)
- University of Southern California (US)
- Corresponding author
- Baylin, Stephen B.
- Jones, Peter A.
- Venue
- Nature Reviews Cancer
- Published
- 2011-09-23
- Volume
- 11
- Issue
- 10
- Pages
- 726-734
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC3307543
- OpenAlex
- W2041686632
- Cited by
- 2,871
- References
- 166
- Citations by year
- 2026: 105 · 2025: 107 · 2024: 130 · 2023: 148 · 2022: 179 · 2021: 207 · 2020: 175 · 2019: 209 · 2018: 192 · 2017: 233 · 2016: 241 · 2015: 248 · 2014: 288 · 2013: 231 · 2012: 171
- FWCI
- 20.15
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Entertainment Industry Foundation
- National Institutes of Health
- National Cancer Institute (R01CA043318, R37CA082422)
- National Institute of Environmental Health Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- cancer epigenome, DNA methylation, chromatin, epigenetic therapy, tumor markers, cancer diagnosis and prognosis, tumor progression, DNA packaging, epigenetic enzymes, cancer metabolism, epigenetic mutations
- MeSH terms
- Animals, Humans, Neoplasms, Genome, Epigenesis, Genetic, History, 20th Century, History, 21st Century, Translational Research, Biomedical, Epigenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
